Search

Your search keyword '"Heytens, Stefan"' showing total 134 results
Start Over Author "Heytens, Stefan"
134 results on '"Heytens, Stefan"'

1. Clinical Reasoning over Tabular Data and Text with Bayesian Networks

Author

Rabaey, Paloma, Deleu, Johannes, Heytens, Stefan, and Demeester, Thomas

Subjects
Computer Science - Artificial Intelligence
Abstract

Bayesian networks are well-suited for clinical reasoning on tabular data, but are less compatible with natural language data, for which neural networks provide a successful framework. This paper compares and discusses strategies to augment Bayesian networks with neural text representations, both in a generative and discriminative manner. This is illustrated with simulation results for a primary care use case (diagnosis of pneumonia) and discussed in a broader clinical context., Comment: AI in Medicine 2024

Published
2024

4. A reference standard for urinary tract infection research: a multidisciplinary Delphi consensus study

Author

Hooton, Thomas, Nicolle, Lindsay, Trautner, Barbara, Gupta, Kalpana, Drekonja, Dimitri, Huttner, Angela, Schneidewind, Laila, Johansen, Truls Erik Bjerklund, Medina-Polo, José, Kranz, Jennifer, Ten Doesschate, Thijs, Ott, Alewijn, Kuil, Sacha, Pulia, Michael, Nwagwu, Veronica, Carpenter, Christopher, Russel, Andrew, Stalenhoef, Janneke, Clark, Sophie, Southerland, Lauren, Notermans, Daan, Fure, Brynjar, Baten, Evert, Ninan, Sean, Gerbrandy-Schreuders, Lara, Van Halem, Karlijn, Blanker, Marco, Naber, Kurt, Pilatz, Adrian, Heytens, Stefan, Vahedi, Ali, Talan, David, Kuijper, Ed, Van Dissel, Jaap, Cals, Jochen, Dubbs, Sarah, Veeratterapillay, Rajan, Sundvall, Pär-Daniel, Bertagnolio, Silvia, Graber, Christopher, Rozemeijer, Wouter, Jump, Robin, Gagyor, Ildiko, Vik, Ingvild, Waar, Karola, Van der Beek, Martha, Bilsen, Manu P, Conroy, Simon P, Schneeberger, Caroline, Platteel, Tamara N, van Nieuwkoop, Cees, Mody, Lona, Caterino, Jeffrey M, Geerlings, Suzanne E, Köves, Bela, Wagenlehner, Florian, Kunneman, Marleen, Visser, Leo G, and Lambregts, Merel M C

Published
2024
Full Text
View/download PDF

6. PATIENTS’ BELIEFS, MEDICATION ADHERANCE AND CONTROLLED HYPERTENSION AMONG HYPERTENSIVE PATIENTS IN VIETNAM

Author

Ho, Hien, primary, Nguyen, Minh Tam, additional, Huynh, Van Minh, additional, Vo, Tam, additional, Tran, Binh Thang, additional, Heytens, Stefan, additional, Devroey, Dirk, additional, Vo, Nu Hong Duc, additional, Dang, Thi Thanh Nha, additional, Doan, Pham Phuoc Long, additional, Nguyen, Vu Phong, additional, Le, Phuoc Hoang, additional, and Hoang, Anh Tien, additional

Published
2024
Full Text
View/download PDF

7. Reducing antibiotic use in uncomplicated urinary tract infections in adult women: a systematic review and individual participant data meta-analysis

Author

Kaußner, Yvonne, Röver, Christian, Heinz, Judith, Hummers, Eva, Debray, Thomas P.A., Hay, Alastair D., Heytens, Stefan, Vik, Ingvild, Little, Paul, Moore, Michael, Stuart, Beth, Wagenlehner, Florian, Kronenberg, Andreas, Ferry, Sven, Monsen, Tor, Lindbæk, Morten, Friede, Tim, and Gágyor, Ildikó

Published
2022
Full Text
View/download PDF

8. Follow-Up of SARS-CoV-2 Antibody Levels in Belgian Nursing Home Residents and Staff Two, Four and Six Months after Primary Course BNT162b2 Vaccination.

Author

Meyers, Eline, De Rop, Liselore, Engels, Fien, Gioveni, Claudia, Coen, Anja, De Burghgraeve, Tine, Digregorio, Marina, Van Ngoc, Pauline, De Clercq, Nele, Buret, Laëtitia, Coenen, Samuel, Deschepper, Ellen, Padalko, Elizaveta, Callens, Steven, Duysburgh, Els, De Sutter, An, Scholtes, Beatrice, Verbakel, Jan Y., Heytens, Stefan, and Cools, Piet

Subjects
NURSING home patients, BOOSTER vaccines, VACCINE effectiveness, ANTIBODY formation, COVID-19 vaccines
Abstract

When COVID-19 vaccines were implemented, nursing home residents (NHRs) and staff (NHS) in Belgium were prioritized for vaccination. To characterize the vaccine response over time in this population and to identify poorly responding groups, we assessed antibody concentrations two (T1), four (T2) and six months (T3) after primary course BNT162b2 vaccination in six groups of infection-naive/infection-primed NHRs/NHS, with/without comorbidity (NHRs only). Participant groups (N = 125 per group) were defined within a national serosurveillance study in nursing homes, based on questionnaire data. Dried blood spots were analyzed using ELISA for the quantification of SARS-CoV-2 S1RBD IgG antibodies. Among all groups, antibody concentrations significantly decreased between T1 and T2/T3, all with a ≥70% decrease at T3, except for infection-primed staff (−32%). Antibody concentrations among infection-naive NHRs were 11.96 times lower than those among infection-primed NHR, while the latter were comparable (x1.05) to infection-primed NHS. The largest proportion [13% (95% CI: 11–24%)] of vaccine non-responders was observed in the group of infection-naive NHRs with comorbidities. A longer interval between infection and vaccination (≥3 months) elicited higher antibody responses. Our data retrospectively show the necessity of timely COVID-19 booster vaccination. Infection-naive NHRs require special attention regarding immune monitoring in future epidemics or pandemics. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. The DAWN antivirals trial: process evaluation of a COVID-19 trial in general practice.

Author

Tare, Dajana, Coenen, Samuel, De Sutter, An, Heytens, Stefan, Devroey, Dirk, Buret, Laetitia, Schoenmakers, Birgitte, Delvaux, Nicolas, Verbakel, Jan Y., Bogaerts, Kris, and van den Bruel, Ann

Subjects
FAMILY medicine, RESEARCH funding, QUALITATIVE research, CLINICAL trials, INTERVIEWING, ANTIVIRAL agents, THEMATIC analysis, RESEARCH methodology, LABOR demand, STAKEHOLDER analysis, COVID-19
Abstract

Background: The DAWN antivirals trial was a multicentric, randomised placebo-controlled trial evaluating antiviral medication for COVID-19 in general practice. The trial was prematurely terminated because of insufficient recruitment. Aim: To explore which factors contributed to the premature termination. Design & setting: General practice in Belgium. Method: Patients were randomised to camostat or placebo (patients and physicians blinded) between June 2021 and July 2022; a third arm evaluating molnupiravir (open label) was opened in March 2022. The outcome assessor was blinded for all comparisons except for the patient reported outcomes in case of molnupiravir. The authors analysed available trial data and evaluated trial context, implementation, and mechanisms of impact based on semi-structured interviews with trial stakeholders. Results: The trial recruited 44 participants; 19 were allocated to camostat (median age 55 years), 8 to molnupiravir (median age 60 years), and 17 to placebo (median age 56 years). There were no serious adverse events in either group. Most difficulties were related to the pandemic context: disruption to routine clinical services; multiple changes to the service model for COVID-19 patients; overwhelmed clinical staff; delays of trial medication; and staff shortages in the sponsor and clinical team. In addition, regulatory approval processes were lengthy and led to additional study procedures. It was felt that the trial started too late, when vaccinations had already begun. Conclusion: The DAWN antivirals trial was stopped prematurely. Although many barriers were related to the pandemic itself, hurdles such as a small and inexperienced sponsor and clinical teams, delays in regulatory processes, and research capacity in routine settings could be overcome by established research infrastructure and standardisation of processes. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

10. A reference standard for urinary tract infection research: a multidisciplinary Delphi consensus study

Author

Bilsen, Manu P, primary, Conroy, Simon P, additional, Schneeberger, Caroline, additional, Platteel, Tamara N, additional, van Nieuwkoop, Cees, additional, Mody, Lona, additional, Caterino, Jeffrey M, additional, Geerlings, Suzanne E, additional, Köves, Bela, additional, Wagenlehner, Florian, additional, Kunneman, Marleen, additional, Visser, Leo G, additional, Lambregts, Merel M C, additional, Hooton, Thomas, additional, Nicolle, Lindsay, additional, Trautner, Barbara, additional, Gupta, Kalpana, additional, Drekonja, Dimitri, additional, Huttner, Angela, additional, Schneidewind, Laila, additional, Johansen, Truls Erik Bjerklund, additional, Medina-Polo, José, additional, Kranz, Jennifer, additional, Ten Doesschate, Thijs, additional, Ott, Alewijn, additional, Kuil, Sacha, additional, Pulia, Michael, additional, Nwagwu, Veronica, additional, Carpenter, Christopher, additional, Russel, Andrew, additional, Stalenhoef, Janneke, additional, Clark, Sophie, additional, Southerland, Lauren, additional, Notermans, Daan, additional, Fure, Brynjar, additional, Baten, Evert, additional, Ninan, Sean, additional, Gerbrandy-Schreuders, Lara, additional, Van Halem, Karlijn, additional, Blanker, Marco, additional, Naber, Kurt, additional, Pilatz, Adrian, additional, Heytens, Stefan, additional, Vahedi, Ali, additional, Talan, David, additional, Kuijper, Ed, additional, Van Dissel, Jaap, additional, Cals, Jochen, additional, Dubbs, Sarah, additional, Veeratterapillay, Rajan, additional, Sundvall, Pär-Daniel, additional, Bertagnolio, Silvia, additional, Graber, Christopher, additional, Rozemeijer, Wouter, additional, Jump, Robin, additional, Gagyor, Ildiko, additional, Vik, Ingvild, additional, Waar, Karola, additional, and Van der Beek, Martha, additional

Published
2024
Full Text
View/download PDF

18. Validation of a rapid SARS-CoV-2 antibody test in general practice

Author

Domen, Julie, primary, Verbakel, Jan Yvan Jos, additional, Adriaenssens, Niels, additional, Scholtes, Beatrice, additional, Peeters, Bart, additional, Bruyndonckx, Robin, additional, De Sutter, An, additional, Heytens, Stefan, additional, Van den Bruel, Ann, additional, Desombere, Isabelle, additional, Van Damme, Pierre, additional, Goossens, Herman, additional, Buret, Laetitia, additional, Duysburgh, Els, additional, and Coenen, Samuel, additional

Published
2023
Full Text
View/download PDF

21. Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign

Author

Meyers, Eline, primary, De Rop, Liselore, additional, Deschepper, Ellen, additional, Duysburgh, Els, additional, De Burghgraeve, Tine, additional, Van Ngoc, Pauline, additional, Digregorio, Marina, additional, Delogne, Simon, additional, Coen, Anja, additional, De Clercq, Nele, additional, Buret, Laëtitia, additional, Coenen, Samuel, additional, De Sutter, An, additional, Scholtes, Beatrice, additional, Verbakel, Jan Y., additional, Cools, Piet, additional, and Heytens, Stefan, additional

Published
2022
Full Text
View/download PDF

22. Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective Cohort Study

Author

Meyers, Eline, primary, Deschepper, Ellen, additional, Duysburgh, Els, additional, De Rop, Liselore, additional, De Burghgraeve, Tine, additional, Van Ngoc, Pauline, additional, Digregorio, Marina, additional, Delogne, Simon, additional, Coen, Anja, additional, De Clercq, Nele, additional, Buret, Laëtitia, additional, Coenen, Samuel, additional, Sutter, An De, additional, Scholtes, Beatrice, additional, Verbakel, Jan Y, additional, Cools, Piet, additional, and Heytens, Stefan, additional

Published
2022
Full Text
View/download PDF

25. Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up

Author

Adriaenssens, Niels, primary, Scholtes, Beatrice, additional, Bruyndonckx, Robin, additional, Van Ngoc, Pauline, additional, Verbakel, Jan Yvan Jos, additional, De Sutter, An, additional, Heytens, Stefan, additional, Van Den Bruel, Ann, additional, Desombere, Isabelle, additional, Van Damme, Pierre, additional, Goossens, Herman, additional, Buret, Laetitia, additional, Duysburgh, Els, additional, and Coenen, Samuel, additional

Published
2022
Full Text
View/download PDF

27. The prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up

Author

Adriaenssens, Niels, primary, Scholtes, Beatrice, additional, Bruyndonckx, Robin, additional, Van Ngoc, Pauline, additional, Verbakel, Jan Y, additional, De Sutter, An, additional, Heytens, Stefan, additional, Van den Bruel, Ann, additional, Desombere, Isabelle, additional, Van Damme, Pierre, additional, Goossens, Herman, additional, Buret, Laëtitia, additional, Duysburgh, Els, additional, and Coenen, Samuel, additional

Published
2022
Full Text
View/download PDF

29. Vaccine Hesitancy towards the COVID-19 Vaccine in a Random National Sample of Belgian Nursing Home Staff Members

Author

Digregorio, Marina, primary, Van Ngoc, Pauline, additional, Delogne, Simon, additional, Meyers, Eline, additional, Deschepper, Ellen, additional, Duysburgh, Els, additional, De Rop, Liselore, additional, De Burghgraeve, Tine, additional, Coen, Anja, additional, De Clercq, Nele, additional, Sutter, An De, additional, Verbakel, Jan Y., additional, Cools, Piet, additional, Heytens, Stefan, additional, Buret, Laëtitia, additional, and Scholtes, Beatrice, additional

Published
2022
Full Text
View/download PDF

31. Humoral and Cellular Responses to COVID-19 Vaccination Indicate the Need for Post-Vaccination Testing in Frail Population

Author

Witkowski, Wojciech, primary, Gerlo, Sarah, additional, De Smet, Evelien, additional, Wejda, Magdalena, additional, Acar, Delphine, additional, Callens, Steven, additional, Heytens, Stefan, additional, Padalko, Elizaveta, additional, Vercruysse, Hanne, additional, Cools, Piet, additional, and Vandekerckhove, Linos, additional

Published
2022
Full Text
View/download PDF

32. Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol

Author

Adriaenssens, Niels, primary, Scholtes, Beatrice, additional, Bruyndonckx, Robin, additional, Verbakel, Jan Y, additional, De Sutter, An, additional, Heytens, Stefan, additional, Van den Bruel, Ann, additional, Desombere, Isabelle, additional, Van Damme, Pierre, additional, Goossens, Herman, additional, Buret, Laëtitia, additional, Duysburgh, Els, additional, and Coenen, Samuel, additional

Published
2022
Full Text
View/download PDF

36. Comparison of Dried Blood Spots and Venous Blood for the Detection of SARS-CoV-2 Antibodies in a Population of Nursing Home Residents

Author

Meyers, Eline, primary, Heytens, Stefan, additional, Formukong, Asangwing, additional, Vercruysse, Hanne, additional, De Sutter, An, additional, Geens, Tom, additional, Hofkens, Kenneth, additional, Janssens, Heidi, additional, Nys, Eveline, additional, Padalko, Elizaveta, additional, Deschepper, Ellen, additional, and Cools, Piet, additional

Published
2021
Full Text
View/download PDF

37. SARS-COV-2 SEROPREVALENCE AMONG NURSING HOME RESIDENTS AND STAFF IN BELGIUM - SCOPE

Author

Meyers, Eline, Deschepper, Ellen, Duysburgh, Els, De Rop, Liselore, De Burghgraeve, Tine, Van Ngoc, Pauline, Di Gregorio, Marina, Delogne, Simon, Coen, Anja, Declercq, Nele, Buret, Laëtitia, Coenen, Samuel, De Sutter, An, Scholtes, Beatrice, Verbakel, Jan, Cools, Piet, and Heytens, Stefan

Abstract

MAIN FINDINGS From February 1st until March 24th, 2021, the SCOPE study measured the proportion of residents and staff members in Belgian nursing homes (NH) that had anti-SARS-CoV-2 antibodies (seroprevalence). In total, 1,572 residents and 1,253 staff members from 69 NHs in Belgium were tested for the presence of SARS-CoV-2 antibodies by a point-of-care rapid test, and responded to a COVID-19 related questionnaire. At the first testing moment (five bimonthly follow-up testing moments are scheduled), we observed the following:  Between February 1st and March 24th, 2021, during the ongoing SARS-CoV-2 vaccination campaign, 69% (95% CI: 63%-74%) of residents and 80% (95% CI: 76%- 83%) of staff in Belgian nursing homes had anti-SARS-CoV-2 antibodies.  At the time of testing 96% of the residents received at least one vaccination dose and 68% were fully vaccinated. For staff this data were respectively 85% and 48%. So, although more residents than staff were vaccinated at the moment of testing, seroprevalence was lower among residents than among staff.  At least one day after receiving one dose of a COVID-19 vaccination, 52% of residents tested positive for anti-SARS-CoV-2 antibodies and 77% tested positive at least one day after receiving two doses. Among staff these findings were higher, being respectively 75% and 98%.  The proportion of residents and staff with antibodies after vaccination was higher among those who reported a previous SARS-CoV-2 infection than among those without a self- reported previous infection. ispartof: SARS-CoV-2 seroprevalence among nursing home residents and staff in Belgium - SCOPE - SCIENTIFIC REPORT RESULTS VISIT 1 – FEBRUARY 2021 status: Published online

Published
2021

38. Prospective SARS-CoV-2 cohort study among primary health care providers during the second COVID-19 wave in Flanders, Belgium

Author

Mariën, Joachim, primary, Ceulemans, Ann, additional, Bakokimi, Diana, additional, Lammens, Christine, additional, Ieven, Margareta, additional, Heytens, Stefan, additional, De Sutter, An, additional, Verbakel, Jan Y, additional, Van den Bruel, Ann, additional, Goossens, Herman, additional, Van Damme, Pierre, additional, Ariën, Kevin K, additional, and Coenen, Samuel, additional

Published
2021
Full Text
View/download PDF

39. Prevalence and Incidence of Antibodies Against Sars-Cov-2 Among Primary Healthcare Providers in Belgium During One Year of the Covid-19 Epidemic: Prospective Cohort Study Protocol

Author

Adriaenssens, Niels, primary, Scholtes, Beatrice, additional, Bruyndonckx, Robin, additional, Verbakel, Jan Y, additional, De Sutter, An, additional, Heytens, Stefan, additional, Van den Bruel, Ann, additional, Desombere, Isabelle, additional, Van Damme, Pierre, additional, Goossens, Herman, additional, Buret, Laëtitia, additional, Duysburgh, Els, additional, and Coenen, Samuel, additional

Published
2021
Full Text
View/download PDF

40. Prospective SARS-CoV-2 cohort study among general practitioners during the second COVID-19 wave in Flanders, Belgium

Author

Mariën, Joachim, primary, Ceulemans, Ann, additional, Bakokimi, Diana, additional, Lammens, Christine, additional, Ieven, Margareta, additional, Heytens, Stefan, additional, Sutter, An De, additional, Verbakel, Jan Y, additional, Van den Bruel, Ann, additional, Goossens, Herman, additional, Van Damme, Pierre, additional, Ariën, Kevin K., additional, and Coenen, Samuel, additional

Published
2021
Full Text
View/download PDF

42. Strategies to reduce antibiotic use in women with uncomplicated urinary tract infection in primary care: protocol of a systematic review and meta-analysis including individual patient data

Author

Heinz, Judith, primary, Röver, Christian, additional, Furaijat, Ghefar, additional, Kaußner, Yvonne, additional, Hummers, Eva, additional, Debray, Thomas, additional, Hay, Alastair D, additional, Heytens, Stefan, additional, Vik, Ingvild, additional, Little, Paul, additional, Moore, Michael, additional, Stuart, Beth, additional, Wagenlehner, Florian, additional, Kronenberg, Andreas, additional, Ferry, Sven, additional, Monsen, Tor, additional, Lindbaek, Morten, additional, Friede, Tim, additional, and Gagyor, Ildiko, additional

Published
2020
Full Text
View/download PDF

43. Prospective SARS-CoV-2 cohort study among primary health care providers during the second COVID-19 wave in Flanders, Belgium.

Author

Mariën, Joachim, Ceulemans, Ann, Bakokimi, Diana, Lammens, Christine, Ieven, Margareta, Heytens, Stefan, Sutter, An De, Verbakel, Jan Y, Bruel, Ann Van den, Goossens, Herman, Damme, Pierre Van, Ariën, Kevin K, Coenen, Samuel, De Sutter, An, Van den Bruel, Ann, and Van Damme, Pierre

Abstract

Background: Primary health care providers (PHCPs) are assumed to be at high risk of a COVID-19 infection, as they are exposed to patients with usually less personal protective equipment (PPE) than other frontline health care workers (HCWs). Nevertheless, current research efforts focussed on the assessment of COVID-19 seroprevalence rates in the general population or hospital HCWs.Objective: We aimed to determine the seroprevalence in PHCPs during the second SARS-CoV-2 wave in Flanders (Belgium) and compared it to the seroprevalence in the general population. We also assessed risk factors, availability of PPE and attitudes towards the government guidelines over time.Methods: A prospective cohort of PHCPs (n = 698), mainly general practitioners, was asked to complete a questionnaire and self-sample capillary blood by finger-pricking at five distinct points in time (June-December 2020). We analysed the dried blood spots for IgG antibodies using a Luminex multiplex immunoassay.Results: The seroprevalence of PHCPs remained stable between June and September (4.6-5.0%), increased significantly from October to December (8.1-13.4%) and was significantly higher than the seroprevalence of the general population. The majority of PHCPs were concerned about becoming infected, had adequate PPE and showed increasing confidence in government guidelines.Conclusions: The marked increase in seroprevalence during the second COVID-19 wave shows that PHCPs were more at risk during the second wave compared to the first wave in Flanders. This increase was only slightly higher in PHCPs than in the general population suggesting that the occupational health measures implemented provided sufficient protection when managing patients. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

45. Additional file 1: of Asymptomatic bacteriuria in older adults: the most fragile women are prone to long-term colonization

Author

Biggel, Michael, Heytens, Stefan, Latour, Katrien, Bruyndonckx, Robin, Goossens, Herman, and Moons, Pieter

Subjects
body regions, nervous system, fungi, urologic and male genital diseases, female genital diseases and pregnancy complications
Abstract

Causative species of asymptomatic bacteriuria identified in sampling rounds S1 or S2 separated by gender. (PDF 143 kb)

Published
2019
Full Text
View/download PDF

46. Additional file 2: of Asymptomatic bacteriuria in older adults: the most fragile women are prone to long-term colonization

Author

Biggel, Michael, Heytens, Stefan, Latour, Katrien, Bruyndonckx, Robin, Goossens, Herman, and Moons, Pieter

Abstract

Prevalence of long-term ABU and transient ABU in different risk factor groups. Long-term ABU and transient ABU cases among 91 participants who were included in the analysis of both sampling rounds S1 and S2 (no ABU episode: n = 47, transient ABU: n = 17, long-term ABU: n = 27). (PDF 112 kb)

Published
2019
Full Text
View/download PDF

50. SAFE PENICILLIN ALLERGY DE-LABELLING IN PRIMARY CARE, A SYSTEMATIC REVIEW AND META-ANALYSIS

Author

Stul, Florian, Heytens, Stefan, Ebo, Didier Gaston, Sabato, Vito, and Piessens, Veerle

Abstract

Ten % of the population is labeled as allergic to penicillin(s), when in fact 90% of these labels are inappropriate. Recent studies have shown that inpatient de-labelling by a direct drug challenge (dDC) is safe in low-risk patients. However, there is a need for outpatient and non-allergist de-labelling.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results